Liquidia Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LQDA | LNTH | UTHR | ALVO | AQST | BCRX | |
|---|---|---|---|---|---|---|
| Market cap | 2.48B | 6.54B | 23.59B | 1.96B | 603.71M | 2.14B |
| P/E (TTM) | 19.9 | 24.2 | 19.7 | — | — | — |
| Forward P/E | 11.9 | 15.7 | 16.3 | 24.1 | -8.4 | 8.9 |
| Price/book | 12.6 | 5.0 | 3.7 | -10.2 | -10.7 | -4.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +15.19% | +83.46% | +24.79% | −30.99% | −30.09% | +30.22% |
| Today | +1.06% | −0.04% | +0.17% | −4.84% | +0.63% | −2.22% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All LQDA news ›Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky
Oct 12, 2026, 14:55 ET Liquidia shareholders took a roughly 57% loss after a court found that Yutrepia infringed two valid United Therapeutics patent claims. The investigation concerns whether investors had an accurate picture of that…
Liquidia Corporation Stock 12‑Month Price Target Cut to $49.33, Implies 76% Upside
TradingView Liquidia Corporation Stock 12‑Month Price Target Cut to $49.33, Implies 76% Upside - According to estimates from 6 analysts, Liquidia Corporation stock's average price target has fallen from $49.67 to $49.33, with forecasts…
Liquidia Drops 5.5% Amid Sector-Wide Selling
AlphaStreet AlphaStreet Newsdesk powered by AlphaStreet Intelligence Liquidia Corporation plunged 5.5% on Tuesday as a broad selloff swept through specialty pharmaceutical stocks, with the company’s shares caught in a sector-wide downdraft…
LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation
A court finding that Yutrepia infringed two valid claims of United Therapeutics' '327 patent has put the drug's PH-ILD indication and broader availability at risk. SueWallSt notifies investors of a pending investigation into potential…
United Therapeutics Prevails In Patent Litigation Against Liquidia
Foley Wins Law Firm of the Year, Two Partners Named Attorneys of the Year at 2026 Texas Legal Awards Innovation in Energy & Infrastructure Aviation & Aircraft Transactions Advances in Health Care & Life Sciences Banking & Finance, Cannabis…
LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities GlobeNewswire 06, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Liquidia Corporation (âLiquidiaâ or the âCompanyâ)…
Liquidia Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Liquidia (LQDA)
LQDA shareholders who lost money after a court found that Yutrepia infringed two valid United Therapeutics patent claims may have the right to seek recovery. The investigation includes Liquidia's forecast of more than $1 billion in 2027…
McDermott Will & Schulte wins significant patent trial against Liquidia over YUTREPIA® PH-ILD treatment
Oct 6 – Oct 7 Oct 19 – Oct 23 November 12 – 13, 2026 Read time: 2 min Global law firm McDermott Will & Schulte secured a significant trial victory on behalf of United Therapeutics Corporation (UTC) in its Hatch-Waxman litigation against…
Liquidia (LQDA) – Research Analysts’ Weekly Ratings Changes
Posted by Defense World Staff on Oct 6th, 2026 Liquidia (NASDAQ: LQDA) recently received a number of ratings updates from brokerages and research firms: Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder…
A Look at Liquidia Corp (LQDA) After 3.5% Decline -- GF Value $284.08 vs Price $27.64
On October 05, 2026, Liquidia Corp LQDA shares fell 3.5% to a current price of $27.64, marking a significant decline within its 52-week range of $21.94 to $93.61. This drop follows a troubling trend, as the stock has decreased by 62.5%…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com8
-
gurufocus.com7
-
marketbeat.com7
-
seekingalpha.com6
-
economictimes.indiatimes.com5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 72 articles, not a forecast.